Two of the pilots will be funded by Penn’s ADCC and will focus on Alzheimer’s disease (AD) and related neurodegenerative disorders. The remaining pilots will be supported by funding from the Perelman School of Medicine at Penn (PSOM) to the IOA and will focus on aging and aging-related diseases. More information can be found here.